Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Gen-Probe, Molecular Light Technology Ltd. deal

GPRO paid $7.2 million in cash for 65.6% of the outstanding

Read the full 110 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE